This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gerson, S. L. Articles by Srinivasen, S. Search for Related Content PubMed PubMed Citation Articles by Gerson, S. L. Articles by Srinivasen, S.

Leukocyte O⁶-Alkylguanine-DNA Alkyltransferase from Human Donors Is Uniformly Sensitive to O⁶-Benzylguanine¹

Division of Hematology/Oncology and the Ireland Cancer Center at Case Western Reserve University and University Hospital of Cleveland, Cleveland, Ohio 44106 [S. L. G., J. S., L. L., S. S.], and Department of Physiology, Pennsylvania State University School of Medicine, Hershey, Pennsylvania 17033 [A. E. P.]

O⁶-Alkylguanine-DNA alkyltransferase (AGT) is the key DNA repair protein responsible for resistance to chloroethylating and methylating agents that attack at the O⁶ position of guanine. O⁶-Benzylguanine (BG), a potent inhibitor of AGT, has recently entered clinical trials. A number of point mutations and at least one human polymorphism within AGT are associated with AGT resistance to inactivation by BG. In this study, we evaluated AGT inhibition by BG in an in vitro assay of peripheral blood mononuclear cell AGT from 56 normal donors, 42 Caucasians, and 14 Japanese. AGT activity ranged from 2.7 to 21.9 fmol/µg DNA and was similar in Japanese and Caucasian donors. Depletion of AGT by BG was uniform in all donors with mean ED₅₀s of 0.37 µM BG in Caucasians and 0.36 µM BG in Japanese. To determine whether the gly160arg AGT polymorphism described in the Japanese population, and recently shown to be BG resistant, could be detected by this assay, we mixed purified gly160arg AGT protein with blood mononuclear cell extract and measured in vitro BG inactivation. The ED₅₀ for the mixture of the gly160arg AGT and mononuclear cell extract was 9 µM BG. On the basis of results in 56 donors, we conclude that BG-resistant AGT, defined as an ED₅₀ in mononuclear cells of >1 µM BG, is present in 0 of 56 donors, (95% confidence interval, 0–6%), suggesting that polymorphisms producing AGT-resistant BG are unusual in humans.

This article has been cited by other articles:

				C. Cohet, S. Borel, F. Nyberg, A. Mukeria, I. Bruske-Hohlfeld, V. Constantinescu, S. Benhamou, P. Brennan, J. Hall, and P. Boffetta Exon 5 Polymorphisms in the O6-Alkylguanine DNA Alkyltransferase Gene and Lung Cancer Risk in Non-Smokers Exposed to Second-Hand Smoke Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 320 - 323. [Abstract] [Full Text] [PDF]

				T. B. Kaur, J. M. Travaline, J. P. Gaughan, J. P. Richie Jr., S. D. Stellman, and P. Lazarus Role of Polymorphisms in Codons 143 and 160 of the O6-Alkylguanine DNA Alkyltransferase Gene in Lung Cancer Risk Cancer Epidemiol. Biomarkers Prev., March 1, 2000; 9(3): 339 - 342. [Abstract] [Full Text]